SSX3 Protein (Transcript Variant 1) (Myc-DYKDDDDK Tag)

Catalog No. ABIN2732734

This Recombinant SSX3 protein is expressed in HEK-293 Cells.

Quick Overview for SSX3 Protein (Transcript Variant 1) (Myc-DYKDDDDK Tag) (ABIN2732734)

Target: SSX3 (Synovial Sarcoma, X Breakpoint 3 (SSX3))

Protein Type: Recombinant

Origin: Human

Source: HEK-293 Cells

Application: Antibody Production (AbP), Standard (STD)

Purity: > 80 % as determined by SDS-PAGE and Coomassie blue staining

Product Details

Protein Characteristics: Transcript Variant 1

Purification tag / Conjugate: This SSX3 protein is labelled with Myc-DYKDDDDK Tag.

Characteristics:

• Recombinant human SSX3 (transcript variant 1) protein expressed in HEK293 cells.
• Produced with end-sequenced ORF clone

Application Details

Application Notes: Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays

Comment:

The tag is located at the C-terminal.

Restrictions: For Research Use only

Handling

Concentration: 50 μg/mL

Buffer: 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.

Storage: -80 °C

Storage Comment: Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.

Target Details

Target: SSX3 (Synovial Sarcoma, X Breakpoint 3 (SSX3))

Alternative Name: Ssx3

Background: The product of this gene belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneous humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. While some of the related SSX genes are involved in t(X18)(p11.2q11.2) translocations that are characteristically found in all synovial sarcomas, this gene does not appear to be involved in such translocations.

Molecular Weight: 21.5 kDa

NCBI Accession: NP_066294